Announcements_Investors_AIM Bio

AIM Vaccine

--.--

Spot Price (HKD)

--.--

HKSE Market Value（million）
--.--

Highest Today (HKD)
--.--

Lowest Today (HKD)

As of:（Beijing Time). The offer may have a delay of 15 minutes or above.
Information/data source: SINA FINANCE

Home > Investors > Announcements

Investors

NOTICE OF BOARD MEETING
2023-03-17

VOLUNTARY ANNOUNCEMENT - TETRAVALENT MENINGOCOCCAL CONJUGATE VACCINE CANDIDATE OFFICIALLY COMMENCED CLINICAL TRIAL
2023-03-17

VOLUNTARY ANNOUNCEMENT - UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS; BUSINESS UPDATES
2023-03-14

INSIDE INFORMATION-(1) PROPOSED ISSUANCE OF UNLISTED RMB DENOMINATED ORDINARY SHARES (2) PROPOSED AUTHORIZATIONS TO THE BOARD RELATING TO THE PROPOSED ISSUANCE (3) PROPOSED EGM AND CLASS MEETINGS
2023-03-08

PROFIT WARNING
2023-03-03

Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
2023-03-01

VOLUNTARY ANNOUNCEMENT - MRNA COVID-19 VACCINE CANDIDATES AGAINST COVID-19 VARIANTS AND ORIGINAL STRAIN OBTAINED CLINICAL TRIAL APPROVALS IN PAKISTAN
2023-02-15

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
2023-02-06

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
2023-01-06

(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022
2023-01-06

(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
2023-01-06

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022
2022-12-01

Next Day Disclosure Return
2022-11-02

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
2022-11-01

VOLUNTARY ANNOUNCEMENT —— EV71-CA16 BIVALENT HFMD VACCINE CANDIDATE OBTAINED THE CLINICAL TRIAL APPROVAL ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
2022-10-31

PARTIAL EXERCISE OF THE OVER-ALLOTMENT OPTION, STABILIZING ACTIONS AND END OF STABILIZATION PERIOD
2022-10-28

VOLUNTARY ANNOUNCEMENT —— FREEZE-DRIED HUMAN RABIES VACCINE CANDIDATE (SERUM-FREE VERO CELL) OBTAINED THE CLINICAL TRIAL APPROVAL ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
2022-10-24

Announcement of Allotment Results
2022-10-05

Articles of Association
2022-10-05

Terms of Reference of the Audit Committee of the Board of Directors
2022-10-05

Terms of Reference of the Remuneration and Appraisal Committee of the Board of Directors
2022-10-05

Terms of Reference of the Nomination Committee of the Board of Directors
2022-10-05

List of Directors and Their Roles and Functions
2022-10-05

GLOBAL OFFERING
2022-09-23

GLOBAL OFFERING
2022-09-23

GREEN APPLICATION FORM
2022-09-23